Beranda068270 • KRX
add
Celltrion Inc
Tutup sebelumnya
₩176.000,00
Rentang hari
₩173.050,00 - ₩176.500,00
Rentang tahun
₩144.615,31 - ₩188.800,00
Kapitalisasi pasar
40,44 T KRW
Volume Rata-Rata
466,80 rb
Rasio P/E
70,94
Hasil dividen
0,39%
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
| (KRW) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Pendapatan | 961,46 M | 9,91% |
Biaya operasional | 301,28 M | 2,01% |
Laba bersih | 61,17 M | -21,59% |
Margin laba bersih | 6,36 | -28,70% |
Penghasilan per saham | 276,00 | -20,06% |
EBITDA | 319,79 M | 56,22% |
Tarif pajak efektif | -20,74% | — |
Neraca
Total aset
Total liabilitas
| (KRW) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Investasi tunai jangka pdk | 824,00 M | -20,06% |
Total aset | 20,55 T | 2,10% |
Total liabilitas | 3,89 T | 24,20% |
Total ekuitas | 16,66 T | — |
Saham yang beredar | 220,28 jt | — |
Harga terhadap nilai buku | 2,35 | — |
Tingkat pengembalian aset | 2,93% | — |
Tingkat pengembalian modal | 3,14% | — |
Arus Kas
Perubahan kas bersih
| (KRW) | Jun 2025info | Perubahan Y/Y |
|---|---|---|
Laba bersih | 61,17 M | -21,59% |
Kas dari operasi | 188,14 M | -35,92% |
Kas dari investasi | -115,46 M | -211,15% |
Kas dari pembiayaan | -196,36 M | 20,36% |
Perubahan kas bersih | -178,62 M | -213,72% |
Arus kas bebas | 92,77 M | -9,21% |
Tentang
Celltrion, Inc. is a biopharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion. Celltrion's founder, Seo Jung-jin, is the richest person in South Korea. Seo Jung-jin, its founder was awarded the 2021 EY World Entrepreneur Of The Year. Wikipedia
CEO
Didirikan
2002
Situs
Karyawan
2.680
